LBCTR2020043495
Not yet recruiting
Phase 3
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care - SOLIDARITY
WHO0 sites1,000 target enrollmentNovember 4, 2020
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- COVID-19
- Sponsor
- WHO
- Enrollment
- 1000
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Eligibility: consenting adults (age \=18\) hospitalised with definite COVID\-19, not already receiving any of the study drugs, without known allergy or contra\-indications to any of them (in the view of the physician responsible for their care), and without anticipated transfer within 72 hours to a non\-study hospital. Patients invited to join the study will be those who are admitted to a collaborating hospital; no wider recruitment efforts are expected.
Exclusion Criteria
- •Exclusion from study entry: Patients will not be randomised if, in the view of the randomising doctor, ANY of the AVAILABLE study drugs are contra\-indicated (eg, because of patient characteristics, chronic liver or heart disease, or some concurrent medication).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careEUCTR2020-001366-11-LVWorld Health Organization100,000
Active, not recruiting
Phase 1
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careCOVID-19Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-001366-11-IEWorld Health Organisation100,000
Active, not recruiting
Phase 1
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careCOVID-19Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-001366-11-ESFIB-HCSC100,000
Active, not recruiting
Phase 1
An international randomised trial of additional treatments for COVID-19 inhospitalised patients who are all receiving the local standard of careEUCTR2020-001366-11-ROMinistry of Health100,000
Active, not recruiting
Phase 1
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careCOVID-19MedDRA version: 23.0Level: HLTClassification code 10084510Term: Coronavirus infectionsSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-001366-11-PTAICIB100,000